PROFESSIONAL CERTIFICATION

REVIEW AND REFEREE WORK

A. Scientific Review Committees

2002 Special Emphasis Panel/Scientific Review Group for “Comprehensive International Program of Research on AIDS (CIPRA), National Institute of Allergy and Infectious Diseases

2004-2008 Scientific Advisory Committee, Adult General Clinical Research Center, University of Colorado Denver School of Medicine

2004 Special Emphasis Panel/Scientific Review Group for program project grant in HIV recombination, National Institute of Allergy and Infectious Diseases

2004-present Study Monitoring Committee, University of Colorado Hospital Clinical Translational Research Center, University of Colorado Denver School of Medicine

2004-2007 Optimization of Antiretroviral Therapy Scientific Committee, AIDS Clinical Trials Group, National Institute of Allergy and Infectious Diseases

2005-2008 Strategic Initiative Review Committee, University of Colorado Denver School of Medicine

2007 Evaluation Committee for Chancellors’ Bridge Funding Awards, University of Colorado Denver

2007-present Scientific Agenda Steering Committee, AIDS Clinical Trials Group, National Institute of Allergy and Infectious Diseases

2008-present Scientific Advisory and Review Committee, Colorado Clinical and Translational Sciences Institute

2008 Special Emphasis Panel/Scientific Review Group for International Clinical, Operations and Health Services Research Training Awards for AIDS and TB, National Institute of Allergy and Infectious Diseases

2008 Special Emphasis Panel/Scientific Review Group for AIDS International Training and Research Program, National Institute of Allergy and Infectious Diseases

2008 Abstract Review Committee, 2009 Western Regional Meeting, Carmel, CA

2007-2011 Optimization of Co-Infection and Co-Morbidity Management Scientific Committee, AIDS Clinical Trials Group, National Institute of Allergy and Infectious Diseases (Vice Chair 2007-2009, Chair 2009-2011)

2010 Special Emphasis Panel/Scientific Review Group for Methods for Prevention Packages (MP311) R01, National Institute of Allergy and Infectious Diseases

2011 Panel for Review of Infections and Immunoepidemiology Branch, National Cancer Institute

2011-2012 Co-infections and Malignancies Subcommittee, AIDS Clinical Trials Group, National Institute of Allergy and Infectious Diseases

2011-present Independent Safety Monitor, “An Open Label Study in Adults with Atopic Dermatitis to Assess Variability in Immune Response to Fluzone® Intradermal Vaccine,” National Institute of Allergy and Infectious Diseases

2011-present Chair, Safety Monitoring Committee for ACTG study “A5225/HiFLAC, A Phase I/II Dose-Finding Study of High-Dose Fluconazole Treatment in AIDS-Associated Cryptococcal Meningitis,” National Institute of Allergy and Infectious Diseases
B. Journal Referee

1996 Ad hoc reviewer for RNA

1999-present Ad hoc reviewer for Clinical and Diagnostic Laboratory Immunology, Journal of Infectious Diseases, Blood, Antiviral Therapy, Journal of Virology, AIDS Research and Human Retroviruses, Journal of Virological Methods, Molecular Therapy and Genomics, JAIDS, Journal of Clinical Virology, Clinical Infectious Diseases

INVITED EXTRAMURAL LECTURES AND PRESENTATIONS

1994 Johns Hopkins University School of Medicine Cancer Therapy Program, "Ribozymes as Antiretroviral Agents," Johns Hopkins University, Baltimore, Maryland

1996 Biology Seminar Series, "Catalytic RNA as a Therapeutic: Problems and Promises," Truman State University, Kirksville, Missouri

1997 Molecular Biology Seminar Series, "The Effect of Structure in a Long Substrate RNA on Ribozyme Cleavage Efficiency," Beckman Research Institute of the City of Hope, Duarte, California

1998 34th Annual Internal Medicine Program, "Treatment of HIV in 1998," Estes Park, Colorado

1998 Progress in Medicine Seminar Series, "The Role of Human Herpesvirus 8 in Kaposi's sarcoma," University of Zimbabwe School of Medicine, Harare, Zimbabwe

1998 World Health Communications Continuing Medical Education Program: Comprehensive Management of HIV Disease, “Human Herpesvirus 8 as a Cause of HIV-Related Malignancies,” Boca Raton, Florida

1999 Department of Pathology Research Seminar Series, "Human Herpesvirus 8 and the Pathogenesis of Kaposi's Sarcoma and Other Malignancies," School of Veterinary Medicine, Colorado State University, Fort Collins, Colorado

1999 Second Workshop Related to HIV/AIDS in China, "Human Herpesvirus 8: Role in Kaposi's Sarcoma," Chinese Academy of Medical Sciences, Beijing, China

1999 World Health Communications Continuing Medical Education Program: Protease Inhibitors in Practice: Myth vs Reality, “Resistance Issues Affecting Protease Inhibitor Therapy,” Coral Gables, Florida

2000 NIH Symposium on the Biology of the Skin, “Molecular Approaches to Treatment of Infectious Diseases,” Snowmass, Colorado

2000 NIH Symposium on the Biology of the Skin, “Human Herpesvirus 8 and KS Pathogenesis,” Snowmass, Colorado

2000 University of Colorado Outreach Program, “Update on HIV Pathogenesis and Treatment,” Campbell County Memorial Hospital, Gillette, Wyoming

2001 Challenges in Infectious Diseases – 2001, “HIV in Primary Care,” LDS Hospital, Salt Lake City, Utah

2001 Progress in Medicine Seminar Series, "KSHV Replication and KS Disease,” University of Zimbabwe School of Medicine, Harare, Zimbabwe

2001 University of Colorado Outreach Program, “Update on HIV Pathogenesis and Treatment,” Montrose Memorial Hospital, Montrose, Colorado

2002 University of Colorado CME Program “Resistance Education,” Beverly Hills, CA

2002 University of Colorado CME Program “Resistance Education,” World Wide Web conferences

2003 University of Colorado CME Program “Resistance Education,” Beverly Hills, CA

2003 University of Colorado CME Program “Resistance Education,” Great Neck, NY

2003 Medical Grand Rounds “Insights into the Kaposi’s Sarcoma Epidemic in Southern Africa”, University of California, San Francisco

2003 Association of Public Health Laboratories Infectious Disease Conference, “Molecular Methods for the Detection and Quantitation of HHV-8 (KSHV) Infection,” Denver, Colorado

2004 Bugs and Drugs Symposium, “HIV Update”, Denver, Colorado

2004-present Semi-annual Community Update on HIV Research, Colorado AIDS Education and Training Center, Denver, Colorado

2004 Shadow Cliff Retreat, “HIV 101”, Grand Lake, Colorado

2004 “The AIDS Epidemic in Africa: How Clinical Research Can Make a Difference”, Infectious Disease Division, Washington University Medical School, St. Louis, Missouri

2005 Shadow Cliff Retreat, “HIV Treatment Update”, Grand Lake, Colorado

2006 22^nd Annual Clinical Virology Symposium, “The Global Impact of Therapy on HIV/AIDS”, Clearwater Beach, Florida

2006 Shadow Cliff Retreat, “HIV Treatment 2006”, Grand Lake, Colorado

2006 African Institute of Biomedical Science and Technology, “AIDS-KS in Zimbabwe”, Harare, Zimbabwe

2006 Invited Discussant, Community Benefits in International Research Panel, 8^th Annual Meeting of the American Society for Bioethics and Humanities, Denver

2007 Session Co-chair, African International Conference on Immunity, Victoria Falls, Zimbabwe

2007 Shadow Cliff Retreat, “New HIV Drugs and Treatment Strategies”, Grand Lake, Colorado

2007 Plenary Speaker, “Baseline Analysis in the ACTG study to Prospectively Evaluate Antiretroviral Therapy in Resource-Limited Settings (PEARLS).” Annual Meeting of the AIDS Clinical Trials Group, Washington, D.C.

2008 Shadow Cliff Retreat, “HIV Treatment 2008”, Grand Lake, Colorado

2008 Plenary Speaker, “A DSMB Finding in the ACTG study to Prospectively Evaluate Antiretroviral Therapy in Resource-Limited Settings (PEARLS).”Annual Meeting of the AIDS Clinical Trials Group, Washington, D.C.

2009 Plenary Speaker, “The PEARLS Study, a Multinational Clinical Trial of HIV Treatment,” Harvard Schering-Plough 17^th Annual Workshop, Harvard School of Public Health, Boston, MA.

2009 Shadow Cliff Retreat, “HIV Update: 10 Questions,” Grand Lake, Colorado

2009 Plenary Speaker, “Globalization of Antiretroviral Therapy,” Annual Meeting of the Rocky Mountain Virology Club, Pingree Park, Colorado

2009 Plenary Speaker, “Clinical and Virological Outcomes of Antiretroviral Therapy for AIDS-Related Kaposi’s Sarcoma in Zimbabwe,” U.S. Military HIV Research Program Site Investigator Meeting, Chiang Mai, Thailand.

2010 Shadow Cliff Retreat, “HIV Treatment 2010”, Grand Lake, Colorado

2010 Plenary Speaker, “AIDS-KS in Zimbabwe,” Annual Research Conference, UZ-UCSF Collaborative Research Programme in Women’s Health, Harare, Zimbabwe.

2011 Shadow Cliff Retreat, “Ten Hot Topics in HIV Care”, Grand Lake, Colorado
TEACHING RECORD